Prudential PLC Vertex Pharmaceuticals Inc Transaction History

Prudential PLC

$19.6 Billion
Q1 2025

A detailed history of Prudential PLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Prudential PLC holds 20,067 shares of VRTX stock, worth $7.36 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

20,067

Previous 25,518 21.36%

Holding current value

$7.36 Million

Previous $10.3 Million 5.33%

% of portfolio

0.05%

Previous 0.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$402.49 - $513.76 $2.19 Million - $2.8 Million	-5,451 Reduced 21.36%	20,067 $9.73 Million
Q4 2024 Feb 12, 2025	SELL	$396.64 - $516.74 $1.49 Million - $1.95 Million	-3,769 Reduced 12.87%	25,518 $10.3 Million
Q3 2024 Nov 12, 2024	SELL	$460.0 - $505.78 $2.86 Million - $3.15 Million	-6,226 Reduced 17.53%	29,287 $13.6 Million
Q2 2024 Aug 06, 2024	SELL	$392.81 - $485.53 $209,760 - $259,273	-534 Reduced 1.48%	35,513 $16.6 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $631,511 - $690,977	-1,549 Reduced 4.12%	36,047 $15.1 Million
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $2.06 Million - $2.46 Million	-5,998 Reduced 13.76%	37,596 $15.3 Million
Q3 2023 Nov 09, 2023	SELL	$338.18 - $362.46 $2.05 Million - $2.19 Million	-6,055 Reduced 12.2%	43,594 $15.2 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $3.18 Million - $3.56 Million	-10,108 Reduced 16.92%	49,649 $17.5 Million
Q1 2023 May 12, 2023	SELL	$283.23 - $323.1 $678,052 - $773,501	-2,394 Reduced 3.85%	59,757 $18.8 Million
Q4 2022 Feb 08, 2023	BUY	$285.76 - $321.48 $1.11 Million - $1.25 Million	3,879 Added 6.66%	62,151 $17.9 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $4.7 Million - $5.25 Million	17,173 Added 41.78%	58,272 $16.9 Million
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $425,512 - $529,808	1,811 Added 4.61%	41,099 $11.6 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $718,950 - $847,369	3,247 Added 9.01%	39,288 $10.3 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $199,313 - $251,604	-1,126 Reduced 3.03%	36,041 $7.92 Million
Q3 2021 Nov 10, 2021	SELL	$181.39 - $202.99 $474,153 - $530,615	-2,614 Reduced 6.57%	37,167 $6.74 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $7.46 Million - $8.8 Million	39,781 New	39,781 $8.02 Million
Q3 2019 Nov 13, 2019	SELL	$166.23 - $187.09 $207,621 - $233,675	-1,249 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $30,382 - $38,442	-200 Reduced 13.8%	1,249 $207,000
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $218,049 - $250,562	-1,300 Reduced 47.29%	1,449 $279,000
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $141,897 - $165,793	936 Added 51.63%	2,749 $448,000
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $268,559 - $294,141	1,813	1,813 $276,000

Others Institutions Holding VRTX

# of Institutions

1,816

Shares Held

232M

Call Options Held

1.49M

Put Options Held

1.07M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $94.1B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.

Account